A Randomized Phase II Study of Nivolumab Plus Ipilimumab Versus Standard   of Care in Previously Untreated and Advanced Non-Clear Cell Renal Cell   Carcinoma (Suniforecast)

Title:: A Randomized Phase II Study of Nivolumab Plus Ipilimumab Versus Standard of Care in Previously Untreated and Advanced Non-Clear Cell Renal Cell Carcinoma (Suniforecast)
Document type:: Meeting Abstract
Author(s):: Ahrens, Marit; Escudier, Bernard; Boleti, Ekaterini; Grimm, Marc-Oliver; Goupir, Marine Gross; Barthelemy, Pilippe; Gravis, Gwenaelle; Bedekes, Jens; Ivanyi, Philipp; Panic, Andrej; Zschaebitz, Stefanie; Neyrieru, Sylvie; Mellado, Begona; Biel, Anika; Wadell, Tom; Pablo Maroto, Jose; Retz, Margitta; Boegemann, Martin; Rottey, Sylvie; Haanen, John; Oosting, Sjoukje; Castellano, Daniel; Hartmann, Arndt; Bergmann, Lothar
Journal title abbreviation:: Oncology Research and Treatment
Year:: 2020
Journal volume:: 43 Suppl 1
Pages contribution:: 226-226
Print-ISSN:: 2296-5270
TUM Institution:: Urologische Klinik und Poliklinik
BibTeX

Occurrences: